Skip to main content
. 2016 Mar 10;7(16):22605–22622. doi: 10.18632/oncotarget.8027

Figure 7. Gr-1 depletion improves tumor therapeutic effects with Symbioflor-2 to the extent of SL7207.

Figure 7

RenCa tumor bearing mice received a daily injection of 25 μg anti-Gr-1 mAb (α-Gr-1) i.p. A. Progression in host body weight of Gr-1 depleted mice following infection. B. Mortality rate of Gr-1 depleted mice over the course of infection. C. RenCa tumor colonization 48 hpi with and without depletion of Gr-1 D. RenCa tumor development in Gr-1 depleted mice over the course of infection. N=5-8. Mean ± SEM.